Blog

Approval of tenecteplase for stroke in India misguided, says expert
FiercePharma
Plans by Indian drugmaker Gennova to launch its generic clot-buster tenecteplase as a treatment for stroke in India are “incomprehensible,” according to a leading stroke expert. Originally developed by Roche and sold under license by Boehringer …